3,172
Views
23
CrossRef citations to date
0
Altmetric
Report

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis

, , , , , , , , , , ORCID Icon & show all
Pages 927-944 | Received 13 Apr 2017, Accepted 16 May 2017, Published online: 05 Jul 2017

References

  • Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97:14-32; PMID:11133738; https://doi.org/10.1182/blood.V97.1.14
  • Pagliari D, Cianci R, Frosali S, Landolfi R, Cammarota G, Newton EE, Pandolfi F. The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev 2013; 24:455-66; PMID:23791986; https://doi.org/10.1016/j.cytogfr.2013.05.004
  • Waldmann TA. The Biology of IL-15: Implications for cancer therapy and the treatment of autoimmune disorders. J Investig Dermatol Symp Proc 2013; 16:S28-30; PMID:24326545; https://doi.org/10.1038/jidsymp.2013.8
  • Stonier SW, Schluns KS. Trans-presentation: A novel mechanism regulating IL-15 delivery and responses. Immunol Lett 2010; 127:85-92; PMID:19818367; https://doi.org/10.1016/j.imlet.2009.09.009
  • Ota N, Takase M, Uchiyama H, Olsen SK, Kanagawa O. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. J Immunol 2010; 185:6041-8; PMID:20926799; https://doi.org/10.4049/jimmunol.0901834
  • Jabri B, Abadie V. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat Rev Immunol 2015; 15:771-83; PMID:26567920; https://doi.org/10.1038/nri3919
  • Waldmann TA. Targeting the interleukin-15 system in rheumatoid arthritis. Arthritis Rheum 2005; 52:2585-8; PMID:16142738; https://doi.org/10.1002/art.21363
  • Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 2005; 52:2686-92; PMID:16142748; https://doi.org/10.1002/art.21249
  • Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 2003; 112:1571-80; PMID:14617758; https://doi.org/10.1172/JCI200318986
  • Liu Z, Geboes K, Colpaert S, D'Haens GR, Rutgeerts P, Ceuppens JL. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 2000; 164:3608-15; PMID:10725717; https://doi.org/10.4049/jimmunol.164.7.3608
  • Nishiwaki T, Ina K, Goto H, Watanabe O, Tsuzuki T, Furuta R, Ando T, Hibi K, Kusugami K. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. J Gastroenterol 2005; 40:128-36; PMID:15770395; https://doi.org/10.1007/s00535-004-1510-y
  • Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006; 55:334-41; PMID:16162679; https://doi.org/10.1136/gut.2005.076000
  • Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity 2012; 36:907-19; PMID:22749351; https://doi.org/10.1016/j.immuni.2012.06.006
  • Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev 2014; 260:221-34; PMID:24942692; https://doi.org/10.1111/imr.12191
  • Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119:996-1006; PMID:11040186; https://doi.org/10.1053/gast.2000.18149
  • Malamut G, El Machhour R, Montcuquet N, Martin-Lannerée S, Dusanter-Fourt I, Verkarre V, Mention JJ, Rahmi G, Kiyono H, Butz EA, et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010; 120:2131-43; PMID:20440074; https://doi.org/10.1172/JCI41344
  • Korneychuk N, Ramiro-Puig E, Ettersperger J, Schulthess J, Montcuquet N, Kiyono H, Meresse B, Cerf-Bensussan N. Interleukin 15 and CD4+ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen. Gastroenterology 2014; 146:1017-27; PMID:24361466; https://doi.org/10.1053/j.gastro.2013.12.023
  • Schulthess J, Meresse B, Ramiro-Puig E, Montcuquet N, Darche S, Bègue B, Ruemmele F, Combadière C, Di Santo JP, Buzoni-Gatel D, et al. Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity 2012; 37:108-21; PMID:22705105; https://doi.org/10.1016/j.immuni.2012.05.013
  • Ettersperger J, Montcuquet N, Malamut G, Guegan N, Lopez-Lastra S, Gayraud S, Reimann C, Vidal E, Cagnard N, Villarese P, et al. Interleukin 15-Dependent T Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease. Immunity 2016; 45:610-25; PMID:27612641; https://doi.org/10.1016/j.immuni.2016.07.018
  • Zhu X, Wang M, Mavi P, Rayapudi M, Pandey AK, Kaul A, Putnam PE, Rothenberg ME, Mishra A. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010; 139:182-93. e7; PMID:20381491; https://doi.org/10.1053/j.gastro.2010.03.057
  • Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137:1238-49; PMID:19596009; https://doi.org/10.1053/j.gastro.2009.07.007
  • Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE). Am J Gastroenterol 2013; 108:679-92; PMID:23567357; https://doi.org/10.1038/ajg.2013.71
  • Dellon ES. Eosinophilic Esophagitis. Gastroenterol Clin North Am 2013; 42:133-53; PMID:23452635; https://doi.org/10.1016/j.gtc.2012.11.008
  • Bobbala D, Chen XL, Leblanc C, Mayhue M, Stankova J, Tanaka T, Chen YG, Ilangumaran S, Ramanathan S. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia 2012; 55:3010-20; PMID:22890824; https://doi.org/10.1007/s00125-012-2675-1
  • Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, et al. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine 2016; 82:102-11; PMID:26868085; https://doi.org/10.1016/j.cyto.2016.01.020
  • Finch DK, Midha A, Buchanan CL, Cochrane D, Craggs RI, Cruwys S, Grahames C, Kolbeck R, Lowe DC, Maltby J, et al. Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo. Br J Pharmacol 2011; 162:480-90; PMID:20942844; https://doi.org/10.1111/j.1476-5381.2010.01061.x
  • Bernard J, Harb C, Mortier E, Quéméner A, Meloen RH, Vermot-Desroches C, Wijdeness J, van Dijken P, Grötzinger J, Slootstra JW, et al. Identification of an interleukin-15alpha receptor-binding site on human interleukin-15. J Biol Chem 2004; 279:24313-22; PMID:15039446; https://doi.org/10.1074/jbc.M312458200
  • Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS™ technology. J Mol Recognit 2007; 20:283-99; PMID:18074397; https://doi.org/10.1002/jmr.846
  • Ring AM, Lin JX, Feng D, Mitra S, Rickert M, Bowman GR, Pande VS, Li P, Moraga I, Spolski R, et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol 2012; 13:1187-95; PMID:23104097; https://doi.org/10.1038/ni.2449
  • Hori T, Uchiyama T, Tsudo M, Umadome H, Ohno H, Fukuhara S, Kita K, Uchino H. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 1987; 70:1069-72; PMID:3115332
  • Brizzi MF, Avanzi GC, Veglia F, Clark SC, Pegoraro L. Expression and modulation of IL-3 and GM-CSF receptors in human growth factor dependent leukaemic cells. Br J Haematol 1990; 76:203-9; PMID:2151248; https://doi.org/10.1111/j.1365-2141.1990.tb07872.x
  • Mention JJ, Ben Ahmed M, Bègue B, Barbe U, Verkarre V, Asnafi V, Colombel JF, Cugnenc PH, Ruemmele FM, McIntyre E, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125:730-45; PMID:12949719; https://doi.org/10.1016/S0016-5085(03)01047-3
  • Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006; 64:313-9; PMID:16923475; https://doi.org/10.1016/j.gie.2006.04.037
  • Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128:3-20. e6; quiz 21–2; PMID:21477849; https://doi.org/10.1016/j.jaci.2011.02.040
  • Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8:R19; PMID:17291332; https://doi.org/10.1186/gb-2007-8-2-r19
  • Wen T, Stucke EM, Grotjan TM, Kemme KA, Abonia JP, Putnam PE, Franciosi JP, Garza JM, Kaul A, King EC, et al. Molecular Diagnosis of Eosinophilic Esophagitis by Gene Expression Profiling. Gastroenterology 2013; 145:1289-99; PMID:23978633; https://doi.org/10.1053/j.gastro.2013.08.046
  • Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K, Weirauch MT, Vaughn S, Lazaro S, Rupert AM, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 2014; 46:895-900; PMID:25017104; https://doi.org/10.1038/ng.3033
  • Bergamaschi C, Bear J, Rosati M, Beach RK, Alicea C, Sowder R, Chertova E, Rosenberg SA, Felber BK, Pavlakis GN. Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood 2012; 120:e1-8; PMID:22496150; https://doi.org/10.1182/blood-2011-10-384362
  • Lebrec H, Horner MJ, Gorski KS, Tsuji W, Xia D, Pan WJ, Means G, Pietz G, Li N, Retter M, et al. Homeostasis of human NK cells is not IL-15 dependent. J Immunol 2013; 191:5551-8; PMID:24184554; https://doi.org/10.4049/jimmunol.1301000
  • DeGottardi MQ, Okoye AA, Vaidya M, Talla A, Konfe AL, Reyes MD, Clock JA, Duell DM, Legasse AW, Sabnis A, et al. Effect of Anti-IL-15 administration on T cell and NK cell homeostasis in Rhesus Macaques. J Immunol 2016; 197:1183-98; PMID:27430715; https://doi.org/10.4049/jimmunol.1600065
  • Oitate M, Masubuchi N, Ito T, Yabe Y, Karibe T, Aoki T, Murayama N, Kurihara A, Okudaira N, Izumi T. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data. Drug Metab Pharmacokinet 2011; 26:423-30; PMID:21606605; https://doi.org/10.2133/dmpk.DMPK-11-RG-011
  • Yokoyama S, Takada K, Hirasawa M, Perera LP, Hiroi T. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease. J Clin Immunol 2011; 31:1038-44; PMID:21938511; https://doi.org/10.1007/s10875-011-9586-7
  • Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116:536-47; PMID:16453027; https://doi.org/10.1172/JCI26679
  • Setty M, Discepolo V, Abadie V, Kamhawi S, Mayassi T, Kent A, Ciszewski C, Maglio M, Kistner E, Bhagat G, et al. Distinct and synergistic contributions of epithelial stress and adaptive immunity to functions of intraepithelial killer cells and active celiac disease. Gastroenterology 2015; 149:681-91. e10; PMID:26001928; https://doi.org/10.1053/j.gastro.2015.05.013
  • Kinoshita Y, Furuta K, Ishimura N, Ishihara S. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion 2012; 86:238-43; PMID:22964662; https://doi.org/10.1159/000341421
  • Dellon ES, Rusin S, Gebhart JH, Covey S, Higgins LL, Beitia R, Speck O, Woodward K, Woosley JT, Shaheen NJ. Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: A prospective study. Am J Gastroenterol 2015; 110:821-7; PMID:25781367; https://doi.org/10.1038/ajg.2015.57
  • Mishra A. Significance of mouse models in dissecting the mechanism of human eosinophilic gastrointestinal diseases (EGID). J Gastroenterol Hepatol Res 2013; 2:845-53; PMID:25866707; https://doi.org/10.6051/j.issn2224-3992.2013.02.343
  • Niranjan R, Rayapudi M, Mishra A, Dutt P, Dynda S, Mishra A. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13. Immunol Cell Biol 2013; 91:408-15; PMID:23689305; https://doi.org/10.1038/icb.2013.21
  • Schluns KS, Williams K, Ma A, Zheng XX, Lefrançois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168:4827-31; PMID:11994430; https://doi.org/10.4049/jimmunol.168.10.4827
  • Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A, Boone DL. IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A 2003; 100:4724-9; PMID:12671073; https://doi.org/10.1073/pnas.0737048100
  • Zanoni I, Spreafico R, Bodio C, Di Gioia M, Cigni C, Broggi A, Gorletta T, Caccia M, Chirico G, Sironi L, et al. IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions. Cell Rep 2013; 4:1235-49; PMID:24055061; https://doi.org/10.1016/j.celrep.2013.08.021
  • Polansky JK, Bahri R, Divivier M, Duitman EH, Vock C, Goyeneche-Patino DA, Orinska Z, Bulfone-Paus S. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Sci Rep 2016; 6:19699; PMID:26822794; https://doi.org/10.1038/srep19699
  • Anderson BG, Quinn LS. Free IL-15 is more abundant than IL-15 complexed with soluble IL-15 receptor-alpha in murine serum: Implications for the mechanism of IL-15 secretion. Endocrinology 2016; 157:1315-20; PMID:26812159; https://doi.org/10.1210/en.2015-1746
  • Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, Eustis S, Schwartz LW, Tsui P, Appelbaum ER, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 2001; 108:250-7; PMID:11496242; https://doi.org/10.1067/mai.2001.116576
  • Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118:1312-9; PMID:17157662; https://doi.org/10.1016/j.jaci.2006.09.007
  • Hommeida S, Alsawas M, Murad MH, Katzka DA, Grothe RM, Absah I. The Association Between Celiac Disease and Eosinophilic Esophagitis: Mayo Experience and Meta-analysis of the Literature. J Pediatr Gastroenterol Nutr 2016; [Epub ahead of print]; PMID:28045773; https://doi.org/10.1097/MPG.0000000000001499
  • Peterson K, Firszt R, Fang J, Wong J, Smith KR, Brady KA. Risk of autoimmunity in EoE and families: A population-based cohort study. Am J Gastroenterol 2016; 111:926-32; PMID:27215923; https://doi.org/10.1038/ajg.2016.185
  • Johnson JB, Boynton KK, Peterson KA. Co-occurrence of eosinophilic esophagitis and potential/probable celiac disease in an adult cohort: a possible association with implications for clinical practice: Gluten Spectrum in EoE. Dis Esophagus 2016; 29(8):977-82; PMID:26541352; https://doi.org/10.1111/dote.12419
  • Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, Schoepfer AM, Simon D, Simon HU. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67:477-90; PMID:22313241; https://doi.org/10.1111/j.1398-9995.2012.02787.x
  • Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, et al. IL-15 promotes cytokine production of human T helper cells. J Immunol 1996; 156:2400-5; PMID:8786297
  • Holmkvist P, Roepstorff K, Uronen-Hansson H, Sandén C, Gudjonsson S, Patschan O, Grip O, Marsal J, Schmidtchen A, Hornum L, et al. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality. Mucosal Immunol 2015; 8:545-58; PMID:25269704; https://doi.org/10.1038/mi.2014.87
  • Niranjan R, Rajavelu P, Ventateshaiah SU, Shukla JS, Zaidi A, Mariswamy SJ, Mattner J, Fortgang I, Kowalczyk M, Balart L, et al. Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis. Clin Immunol 2015; 157:103-13; PMID:25638412; https://doi.org/10.1016/j.clim.2015.01.007
  • Mishra A, La Perle K, Kwiatkowski S, Sullivan LA, Sams GH, Johns J, Curphey DP, Wen J, McConnell K, Qi J, et al. Mechanism, consequences, and therapeutic targeting of abnormal IL15 signaling in cutaneous T-cell lymphoma. Cancer Discov 2016; 6:986-1005; PMID:27422033; https://doi.org/10.1158/2159-8290.CD-15-1297
  • Saikh KU, Kissner TL, Nystrom S, Ruthel G, Ulrich RG. Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers. Clin Vaccine Immunol 2008; 15:131-7; PMID:18045883; https://doi.org/10.1128/CVI.00320-07
  • Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, Lowichik A, Chen X, Emerson L, Cox K, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 2014; 147:602-9; PMID:24907494; https://doi.org/10.1053/j.gastro.2014.05.036
  • Tang F, Sally B, Lesko K, Discepolo V, Abadie V, Ciszewski C, Semrad C, Guandalini S, Kupfer SS, Jabri B. Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease. J Exp Med [Internet] 2015; 212:1487-95; PMID:26304964; https://doi.org/10.1084/jem.20150303
  • Hoontrakoon R, Chu HW, Gardai SJ, Wenzel SE, McDonald P, Fadok VA, Henson PM, Bratton DL. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 2002; 26:404-12; PMID:11919076; https://doi.org/10.1165/ajrcmb.26.4.4517
  • Rayapudi M, Rajavelu P, Zhu X, Kaul A, Niranjan R, Dynda S, Mishra A, Mattner J, Zaidi A, Dutt P, et al. Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Transl Immunol 2014; 3:e9; PMID:25505954; https://doi.org/10.1038/cti.2013.13
  • Mishra A, Schlotman J, Wang M, Rothenberg ME. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol 2007; 81:916-24; PMID:17194734; https://doi.org/10.1189/jlb.1106653
  • Straumann A, Blanchard C, Radonjic-Hoesli S, Bussmann C, Hruz P, Safroneeva E, Simon D, Schoepfer AM, Simon HU. A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE Families. Allergy 2016; 71:889-900; PMID:26970242; https://doi.org/10.1111/all.12879
  • Sayej WN, Ménoret A, Maharjan AS, Fernandez M, Wang Z, Balarezo F, Hyams JS, Sylvester FA, Vella AT. Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis. Clin Transl Immunol 2016; 5:e88; PMID:27525061; https://doi.org/10.1038/cti.2016.30
  • Arias A., Pérez-Martínez I, Tenías JM, Lucendo AJ. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 2015; 25:208-12; PMID:26510832; https://doi.org/10.1111/apt.13441
  • Lebwohl B, Ludvigsson JF, Green PHR. Celiac disease and non-celiac gluten sensitivity. BMJ 2015; 351:h4347; PMID:26438584; https://doi.org/10.1136/bmj.h4347
  • Nylund L, Kaukinen K, Lindfors K. The microbiota as a component of the celiac disease and non-celiac gluten sensitivity. Clin Nutr Exp 2016; 6:17-24; PMID:26990286; https://doi.org/10.1016/j.yclnex.2016.01.002
  • Harris JK, Fang R, Wagner BD, Choe HN, Kelly CJ, Schroeder S, Moore W, Stevens MJ, Yeckes A, Amsden K, et al. Esophageal microbiome in eosinophilic esophagitis. PloS One 2015; 10:e0128346; PMID:26020633; https://doi.org/10.1371/journal.pone.0128346
  • Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM, Bushman FD, Wang ML. Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 2015; 3:2; PMID:25705378; https://doi.org/10.1186/s40168-015-0085-6
  • Meisel M, Mayassi T, Fehlner-Peach H, Koval JC, O'Brien SL, Hinterleitner R, Lesko K, Kim S, Bouziat R, Chen L, et al. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis. ISME J 2017; 11:15-30; PMID:27648810; https://doi.org/10.1038/ismej.2016.114
  • Thorburn AN, Macia L, Mackay CR. Diet, Metabolites, and “Western-Lifestyle” inflammatory diseases. Immunity 2014; 40:833-42; PMID:24950203; https://doi.org/10.1016/j.immuni.2014.05.014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.